Rexahn Pharmaceuticals announced today that Teva Pharmaceutical Industries has decided, for strategic reasons, not to exercise its option to license RX-3117 from Rexahn.
http://www.pharmpro.com/news/2013/08/rexahn-pharmaceuticals-announces-teva-will-not-exercise-its-option-license-rx-3117
http://www.pharmpro.com/news/2013/08/rexahn-pharmaceuticals-announces-teva-will-not-exercise-its-option-license-rx-3117
No comments:
Post a Comment